ValiRx plc (AIM:VAL)
London · Delayed Price · Currency is GBP · Price in GBX 0.2000
+0.0050 (2.56%)
May 26, 2026, 3:16 PM GMT
ValiRx Market Cap
ValiRx has a market cap or net worth of 1.5 million as of May 26, 2026. Its market cap has decreased by -23.82% in one year.
Market Cap
1.50M
Enterprise Value
545.19K
Revenue
49.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.20
Market Cap Chart
Since October 3, 2006, ValiRx's market cap has decreased from 12.83M to 1.50M, a decrease of -88.33%. That is a compound annual growth rate of -10.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 1.50M | -39.83% |
| Dec 31, 2025 | 2.49M | -14.24% |
| Dec 31, 2024 | 2.90M | -51.94% |
| Dec 29, 2023 | 6.04M | -33.71% |
| Dec 30, 2022 | 9.11M | -61.38% |
| Dec 31, 2021 | 23.58M | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cizzle Biotechnology Holdings | 12.32M |
| Genflow Biosciences | 12.04M |
| Oxford BioDynamics | 8.15M |
| CRISM Therapeutics | 5.95M |
| OptiBiotix Health | 5.94M |
| Thalia Therapeutics | 5.41M |
| Theracryf | 4.94M |
| Nuformix | 4.44M |